TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastasesCarey K. Anders, Lisa A. Carey, Anna Maria Storniolo et al.|Breast Cancer Research and Treatment|2014Cited by 69
TBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple-negative breast cancer (TNBC) central nervous system (CNS) metastases (mets).Carey K. Anders, Lisa A. Carey, Allison M. Deal et al.|Journal of Clinical Oncology|2013Cited by 4